GlassScriptPhysician profile
Bryan Jewell
NPI 1679723597
$2,572.94
in general payments reported to CMS, 2019-2025
29 companies · $458 in 2025
The $458 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $307 · 2021: $421 · 2022: $355 · 2023: $555 · 2024: $371 · 2025: $458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,287 · Education: $95.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,287.27 |
| Education | $95.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $571.69 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $306.22 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $246.80 | 2023-2025 | Myfembree |
| Evofem Biosciences, INC. | $202.76 | 2021-2025 | Phexxi, Solosec, Phexx |
| Astellas Pharma US INC | $158.24 | 2023-2024 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $135.90 | 2021-2024 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $131.63 | 2019-2024 | |
| Therapeuticsmd, INC. | $103.33 | 2019-2022 | |
| Millicent US INC | $100.12 | 2020-2025 | Femlyv |
| Optumhealth Care Solutions, LLC | $70.32 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Organon LLC | $58.01 | 2022-2025 | Jada System, Nexplanon |
| Avion Pharmaceuticals | $57.42 | 2020-2023 | Balcoltra |
| Davol INC. | $47.51 | 2025 | Arista |
| Lupin INC. | $35.09 | 2020-2021 | |
| Myovant Sciences INC. | $34.21 | 2021-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $32.13 | 2024 | |
| Merck Sharp & Dohme LLC | $31.11 | 2022-2024 | Gardasil, Gardasil 9 |
| Vertical Pharmaceuticals, LLC | $30.82 | 2019 | |
| Aspira Women'S Health INC | $29.97 | 2020-2021 | |
| Mylan Pharmaceuticals INC. | $29.82 | 2021 | |
| Medicem INC. | $26.53 | 2020 | |
| Covidien LP | $23.65 | 2019 | |
| Glaxosmithkline, LLC. | $20.16 | 2020 | |
| Mission Pharmacal Company | $16.77 | 2021 | |
| Hologic Sales and Service, LLC | $16.47 | 2021 | |
| Lsi Solutions INC | $15.74 | 2024 | Running Device, Fornisee, Ti-Knot |
| Agile Therapeutics, INC. | $15.25 | 2022 | |
| Allergan, INC. | $13.99 | 2020 | |
| Coopersurgical, INC. | $11.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Jewell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.